Preliminary investigation of gene expression levels of PAPP-A, STC-2, and HIF-1α in SARS-Cov-2 infected patients.
COVID-19
HIF-1α
PAPP-A
SARS-CoV-2
STC-2
Journal
Molecular biology reports
ISSN: 1573-4978
Titre abrégé: Mol Biol Rep
Pays: Netherlands
ID NLM: 0403234
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
31
03
2022
accepted:
14
06
2022
pubmed:
8
7
2022
medline:
14
9
2022
entrez:
7
7
2022
Statut:
ppublish
Résumé
Coronavirus-19 is still considered a pandemic that influences the world. Other molecular alterations should be clearer besides the increasing cytokine storm and pro-inflammatory molecules. Hypoxic conditions that induce HIF-1α lead to stimulate gene expression of STC-2 that targets PAPP-A expression. This study aimed to determine gene expression levels of PAPP-A, STC-2, and HIF-1α in COVID-19 infection. We also aimed to reveal the relationship of these genes with laboratory and clinical data of COVID-19 patients. We extracted RNA from peripheral blood samples of COVID-19(+) and COVID-19(-) individuals. The real-time PCR method was used to measure mRNA expression of PAPP-A, STC-2, and HIF-1α. Gene expression analysis was evaluated by the 2 This is the first study that investigates the relation of PAPP-A, STC-2, and HIF-1α gene expression in patients with COVID-19 infection. Besides the routine laboratory findings, PAPP-A, STC-2, and HIF-1α mRNA expressions may be considered to patients' prognosis as a sign of increased cytokines and pro-inflammatory molecules.
Sections du résumé
BACKGROUND
BACKGROUND
Coronavirus-19 is still considered a pandemic that influences the world. Other molecular alterations should be clearer besides the increasing cytokine storm and pro-inflammatory molecules. Hypoxic conditions that induce HIF-1α lead to stimulate gene expression of STC-2 that targets PAPP-A expression. This study aimed to determine gene expression levels of PAPP-A, STC-2, and HIF-1α in COVID-19 infection. We also aimed to reveal the relationship of these genes with laboratory and clinical data of COVID-19 patients.
MATERIALS AND RESULTS
RESULTS
We extracted RNA from peripheral blood samples of COVID-19(+) and COVID-19(-) individuals. The real-time PCR method was used to measure mRNA expression of PAPP-A, STC-2, and HIF-1α. Gene expression analysis was evaluated by the 2
CONCLUSION
CONCLUSIONS
This is the first study that investigates the relation of PAPP-A, STC-2, and HIF-1α gene expression in patients with COVID-19 infection. Besides the routine laboratory findings, PAPP-A, STC-2, and HIF-1α mRNA expressions may be considered to patients' prognosis as a sign of increased cytokines and pro-inflammatory molecules.
Identifiants
pubmed: 35796937
doi: 10.1007/s11033-022-07710-9
pii: 10.1007/s11033-022-07710-9
pmc: PMC9261127
doi:
Substances chimiques
Glycoproteins
0
HIF1A protein, human
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Intercellular Signaling Peptides and Proteins
0
RNA, Messenger
0
STC2 protein, human
0
Pregnancy-Associated Plasma Protein-A
EC 3.4.24.-
PAPPA protein, human
EC 3.4.24.79
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8693-8699Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Huang C, Wang Y, Li X et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395:497–506. https://doi.org/10.1016/S0140-6736(20)30183-5
doi: 10.1016/S0140-6736(20)30183-5
Boldt HB, Overgaard MT, Laursen LS et al (2001) Mutational analysis of the proteolytic domain of pregnancy-associated plasma protein-A (PAPP-A): classification as a metzincin. Biochem J 358:359. https://doi.org/10.1042/0264-6021:3580359
doi: 10.1042/0264-6021:3580359
pubmed: 11513734
pmcid: 1222068
Conover CA, Chen B-K, Resch ZT (2004) Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts. Bone 34:297–302. https://doi.org/10.1016/j.bone.2003.10.011
doi: 10.1016/j.bone.2003.10.011
pubmed: 14962808
Conover CA, Bale LK, Harrington SC et al (2006) Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Am J Physiol Physiol 290:C183–C188. https://doi.org/10.1152/ajpcell.00199.2005
doi: 10.1152/ajpcell.00199.2005
Conover CA, Faessen GF, Ilg KE et al (2001) Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of Dominant follicle selection and the corpus luteum. Endocrinology 142:2155–2155. https://doi.org/10.1210/endo.142.5.8286
doi: 10.1210/endo.142.5.8286
pubmed: 11316785
Resch ZT, Chen B-K, Bale LK et al (2004) Pregnancy-associated plasma protein A gene expression as a target of inflammatory cytokines. Endocrinology 145:1124–1129. https://doi.org/10.1210/en.2003-1313
doi: 10.1210/en.2003-1313
pubmed: 14657012
Conover CA, Harrington SC, Bale LK, Oxvig C (2007) Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. Am J Physiol Circ Physiol 292:H994–H1000. https://doi.org/10.1152/ajpheart.00798.2006
doi: 10.1152/ajpheart.00798.2006
Chang AC-M, Reddel RR (1998) Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 141:95–99. https://doi.org/10.1016/S0303-7207(98)00097-5
doi: 10.1016/S0303-7207(98)00097-5
pubmed: 9723890
Ishibashi K, Miyamoto K, Taketani Y et al (1998) Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem Biophys Res Commun 250:252–258. https://doi.org/10.1006/bbrc.1998.9300
doi: 10.1006/bbrc.1998.9300
pubmed: 9753616
Jepsen MR, Kløverpris S, Mikkelsen JH et al (2015) Stanniocalcin-2 inhibits mammalian growth by proteolytic inhibition of the insulin-like growth factor axis. J Biol Chem 290:3430–3439. https://doi.org/10.1074/jbc.M114.611665
doi: 10.1074/jbc.M114.611665
pubmed: 25533459
Law AYS, Lai KP, Ip CKM et al (2008) Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Exp Cell Res 314:1823–1830. https://doi.org/10.1016/j.yexcr.2008.03.001
doi: 10.1016/j.yexcr.2008.03.001
pubmed: 18394600
Ito D, Walker JR, Thompson CS et al (2004) Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties. Mol Cell Biol 24:9456–9469. https://doi.org/10.1128/MCB.24.21.9456-9469.2004
doi: 10.1128/MCB.24.21.9456-9469.2004
pubmed: 15485913
pmcid: 522226
Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656–665. https://doi.org/10.1056/NEJMra0910283
doi: 10.1056/NEJMra0910283
pubmed: 21323543
pmcid: 3930928
Van Wyngene L, Vandewalle J, Libert C (2018) Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med 10:e8712. https://doi.org/10.15252/emmm.201708712
doi: 10.15252/emmm.201708712
pubmed: 29976786
pmcid: 6079534
Fitzpatrick SF (2019) Immunometabolism and sepsis: a role for HIF? Front Mol Biosci 6:e00085. https://doi.org/10.3389/fmolb.2019.00085
doi: 10.3389/fmolb.2019.00085
Semenza GL, Jiang B-H, Leung SW et al (1996) Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529–32537. https://doi.org/10.1074/jbc.271.51.32529
doi: 10.1074/jbc.271.51.32529
pubmed: 8955077
Adams J, Difazio L, Rolandelli R et al (2009) HIF-1: a key mediator in hypoxia (Review). Acta Physiol Hung 96:19–28. https://doi.org/10.1556/APhysiol.96.2009.1.2
doi: 10.1556/APhysiol.96.2009.1.2
pubmed: 19264039
Yoon D, Pastore YD, Divoky V et al (2006) Hypoxia-inducible Factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 281:25703–25711. https://doi.org/10.1074/jbc.M602329200
doi: 10.1074/jbc.M602329200
pubmed: 16787915
Kallio PJ (1998) Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J 17:6573–6586. https://doi.org/10.1093/emboj/17.22.6573
doi: 10.1093/emboj/17.22.6573
pubmed: 9822602
pmcid: 1171004
Prabhakar NR (2001) Invited review: oxygen sensing during intermittent hypoxia: cellular and molecular mechanisms. J Appl Physiol 90:1986–1994. https://doi.org/10.1152/jappl.2001.90.5.1986
doi: 10.1152/jappl.2001.90.5.1986
pubmed: 11299293
Schäfer ST, Frede S, Winning S et al (2013) Hypoxia-inducible factor and target gene expression are decreased in patients with sepsis. Anesthesiology 118:1426–1436. https://doi.org/10.1097/ALN.0b013e31828baa67
doi: 10.1097/ALN.0b013e31828baa67
pubmed: 23449494
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25:402–408. https://doi.org/10.1006/meth.2001.1262
doi: 10.1006/meth.2001.1262
pubmed: 11846609
Conover CA, Oxvig C (2017) PAPP-A: a promising therapeutic target for healthy longevity. Aging Cell 16:205–209. https://doi.org/10.1111/acel.12564
doi: 10.1111/acel.12564
pubmed: 28035757
Sanchez BG, Gasalla JM, Sánchez-Chapado M et al (2021) Increase in ischemia-modified albumin and pregnancy-associated plasma protein-A in COVID-19 patients. J Clin Med 10:5474. https://doi.org/10.3390/jcm10235474
doi: 10.3390/jcm10235474
pubmed: 34884175
pmcid: 8658290
Cosma S, Carosso AR, Borella F et al (2021) Prenatal biochemical and ultrasound markers in COVID-19 pregnant patients: a prospective case-control study. Diagnostics 11:398. https://doi.org/10.3390/diagnostics11030398
doi: 10.3390/diagnostics11030398
pubmed: 33652805
pmcid: 7996827
Trilla C, Mora J, Crovetto F et al (2022) First-trimester SARS-CoV-2 infection: clinical presentation, inflammatory markers and obstetric outcomes. Fetal Diagn Ther. https://doi.org/10.1159/000523974
doi: 10.1159/000523974
pubmed: 35263747
Serrano B, Mendoza M, Garcia-Aguilar P et al (2022) Shared risk factors for COVID-19 and preeclampsia in the first trimester: an observational study. Acta Obstet Gynecol Scand. https://doi.org/10.1111/aogs.14371
doi: 10.1111/aogs.14371
pubmed: 35505629
pmcid: 9347999
Lv H, Liu Q, Sun Y et al (2020) Mesenchymal stromal cells ameliorate acute lung injury induced by LPS mainly through stanniocalcin-2 mediating macrophage polarization. Ann Transl Med 8:334–334. https://doi.org/10.21037/atm.2020.02.105
doi: 10.21037/atm.2020.02.105
pubmed: 32355778
pmcid: 7186596
Zhang L, Li M, Wang Z et al (2022) Cardiovascular risk after SARS-CoV-2 infection is mediated by IL18/IL18R1/HIF-1 signaling pathway axis. Front Immunol 12:e780804. https://doi.org/10.3389/fimmu.2021.780804
doi: 10.3389/fimmu.2021.780804
Taniguchi-Ponciano K, Vadillo E, Mayani H et al (2021) Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients. Ann Med 53:197–207. https://doi.org/10.1080/07853890.2020.1858234
doi: 10.1080/07853890.2020.1858234
pubmed: 33345622
Codo AC, Davanzo GG, de Monteiro LB et al (2020) Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab 32:437-446.e5. https://doi.org/10.1016/j.cmet.2020.07.007
doi: 10.1016/j.cmet.2020.07.007
pubmed: 32697943
pmcid: 7367032
Zhu B, Wu Y, Huang S et al (2021) Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection. Immunity 54:1200-1218.e9. https://doi.org/10.1016/j.immuni.2021.04.001
doi: 10.1016/j.immuni.2021.04.001
pubmed: 33951416
pmcid: 8192557
Tian M, Liu W, Li X et al (2021) HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19. Signal Transduct Target Ther 6:308. https://doi.org/10.1038/s41392-021-00726-w
doi: 10.1038/s41392-021-00726-w
pubmed: 34408131
pmcid: 8371950
Rolfo A, Cosma S, Nuzzo AM et al (2022) Increased placental anti-oxidant response in asymptomatic and symptomatic COVID-19 third-trimester pregnancies. Biomedicines 10:634. https://doi.org/10.3390/biomedicines10030634
doi: 10.3390/biomedicines10030634
pubmed: 35327436
pmcid: 8945802
Panagiotou G, Anastasilakis AD, Kynigopoulos G et al (2017) Physiological parameters regulating circulating levels of the IGFBP-4/Stanniocalcin-2/PAPP-A axis. Metabolism 75:16–24. https://doi.org/10.1016/j.metabol.2017.07.003
doi: 10.1016/j.metabol.2017.07.003
pubmed: 28964325
Ortega MA, Fraile-Martínez O, Asúnsolo Á et al (2020) Chronic venous disease patients showed altered expression of IGF-1/PAPP-A/STC-2 axis in the vein wall. Biomed Res Int 2020:1–8. https://doi.org/10.1155/2020/6782659
doi: 10.1155/2020/6782659
Hjortebjerg R, Bojsen-Møller KN, Søeby M et al (2021) Metabolic improvement after gastric bypass correlates with changes in IGF-regulatory proteins stanniocalcin-2 and IGFBP-4. Metabolism 124:154886. https://doi.org/10.1016/j.metabol.2021.154886
doi: 10.1016/j.metabol.2021.154886
pubmed: 34506805
Espelund US, Bjerre M, Hjortebjerg R et al (2017) Insulin-like growth factor bioactivity, stanniocalcin-2, pregnancy-associated plasma protein-A, and IGF-binding protein-4 in pleural fluid and serum from patients with pulmonary disease. J Clin Endocrinol Metab 102:3526–3534. https://doi.org/10.1210/jc.2017-00033
doi: 10.1210/jc.2017-00033
pubmed: 28911149
Iunusova N V, Spirina L V, Kondakova LA, et al [Relationship between the expression levels of PAPP-A metalloproteinase and growth and transcriptional factors in endometrial cancer]. Izv Akad Nauk Seriia Biol 284–91
Jin M, Shi N, Wang M et al (2020) CD45: a critical regulator in immune cells to predict severe and non-severe COVID-19 patients. Aging 12:19867–19879. https://doi.org/10.18632/aging.103941
doi: 10.18632/aging.103941
pubmed: 33065551
pmcid: 7655207